SEARCH RESULTS FOR: "Tag: VRTX"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2022(2)
2021(1)
2020(1)
2018(8)
2017(18)
2016(7)
2015(5)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(3)
Analyst Update(7)
Best and Worst Stocks(6)
Buzz Stocks(7)
By the Numbers(2)
Editor's Pick(1)
Expectational Analysis(2)
Ezines(1)
Indexes and ETFs(1)
Intraday Option Activity(3)
Investor Sentiment(1)
Market Recap(1)
Midday Market Check(2)
Opening View(3)
Options Recommendations(1)
Quantitative Analysis(8)
Stock Market News(3)
Stocks On the Move(3)
Technical Analysis(3)
VIX and Volatility(1)

11/14/2022 1:15 PM
Biotechnology concern Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been a standout during the past year, joining some of its sector peers in notable annual returns. The security surged to a...
3/14/2022 2:14 PM
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up 1.6% at $240.25 at last check. Shares saw a positive post-earnings reaction in late January, and then surged to their highest level since Octobe...
6/11/2021 10:25 AM
The shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) are down 11.7% at $191.50 at last check, after the company announced an experimental drug it was developing to treat a rare genetic cond...
1/31/2020 10:53 AM
Earnings have been in focus all week on Wall Street, and that's continuing today, with a number of big names making notable moves after their quarterly reports. Leading the way of course is Amazon.co...
12/24/2018 11:43 AM
Crispr Therapeutics AG (NASDAQ:CRSP) is trading up 9.9% at $24.98 today, after it was revealed Friday evening that cystic fibrosis specialist Vertex Pharmaceuticals (VRTX) took a 10.1% stake in the ge...